miR30a Inhibits LOX Expression and Anaplastic Thyroid Cancer Progression

Cancer Research - United States
doi 10.1158/0008-5472.can-14-2304
Full Text
Abstract

Available in full text

Date
Authors
Publisher

American Association for Cancer Research (AACR)

Related search

Epidermal Growth Factor Receptor (EGFR) Is Overexpressed in Anaplastic Thyroid Cancer, and the EGFR Inhibitor Gefitinib Inhibits the Growth of Anaplastic Thyroid Cancer

Clinical Cancer Research
Cancer ResearchOncology
2004English

Global RNA Expression and DNA Methylation Patterns in Primary Anaplastic Thyroid Cancer

Cancers
Cancer ResearchOncology
2020English

Unusual Manifestation of Anaplastic Thyroid Cancer

Acta medica (Hradec Kralove)
Medicine
2008English

Treatment With Lenvatinib to Anaplastic Thyroid Cancer :

JOURNAL OF JAPAN SOCIETY FOR HEAD AND NECK SURGERY
2018English

Anaplastic Thyroid Cancer Evolved From Papillary Carcinoma

Archives of Otolaryngology–Head & Neck Surgery
2003English

H-Prune Affects Anaplastic Thyroid Cancer Invasion and Metastasis

Oncology Reports
MedicineCancer ResearchOncology
2016English

Endometrioid Adenocarcinoma Metastatic to the Thyroid, Presenting Like Anaplastic Thyroid Cancer

Case Reports in Endocrinology
EndocrinologyMetabolismDiabetes
2011English

A New Aurora in Anaplastic Thyroid Cancer Therapy

International Journal of Endocrinology
EndocrineEndocrinologyMetabolismAutonomic SystemsDiabetes
2014English

Downregulation of Long Noncoding RNA CASC15 Inhibits Progression, Migration and Invasion of Papillary Thyroid Cancer

Archives of Medical Science
Medicine
2019English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy